The most common IHC breast cancer prognostic markers are the hormonal receptors, comprising the estrogen receptor (ER) and the progesterone receptor (PgR), the human epidermal growth factor receptor-2 (HER2), and the cellular marker for proliferation ki67. This evidence concerns the gene ESR1 and breast carcinoma.